Genta, Inc (fka GNTAQ)

[The Holder]

Guys, I hate to say it, but...

...short-term, this stock is going to continue to fall. The fact of the matter is that too many people who held millions of shares were banking on CLL approval. Don't let nutriman get it twisted by saying that CLL denial was baked into the current price at .008...obviously it wasn't.

This stock won't run again and will continue to fall until one of 2 things happen:

1) Partnership
2) Funding to continue operations

There will be no analytical results on the Agenda trial until September at the absolute earliest, which will be 6 months after the last patient is expected to enroll in the trial.